manufacturing

News

Lilly names Pennsylvania site for its latest US facility

Eli Lilly has revealed the fourth new manufacturing site in its $27 billion capital investment spree in the US - a $3.5bn facility in Pennsylvania.

News

J&J jumps on the MFN pricing train

Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.

Market Access

Inside Sandoz: How women leaders are driving sustainability ...

News

US vulnerable to China's API dominance, says report

China has such a dominant position in pharmaceutical ingredient production that there is a risk it will weaponise access, says a Congressional report.

News

Lilly reveals $3bn orforglipron facility in Netherlands

After so many announcements of new facility builds in the US, Eli Lilly has made a welcome commitment to a European investment.

News

Lilly climbs on stellar GLP-1 drug sales gain

Eli Lilly is celebrating a massive 54% increase in its third-quarter revenues to $17.6 billion, driven by its medicines for diabetes and obesity.

Lilly names Pennsylvania site for its latest US facility

J&J jumps on the MFN pricing train

Inside Sandoz: How women leaders are driving sustainability ...

US vulnerable to China's API dominance, says report

Lilly reveals $3bn orforglipron facility in Netherlands

Lilly climbs on stellar GLP-1 drug sales gain

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

manufacturing

Editor's Picks